ADVERTISEMENT

Europe

Richter And Bio-Thera Shake Hands On $100m+ European Ustekinumab Deal

Richter And Bio-Thera Shake Hands On $100m+ European Ustekinumab Deal

Gedeon Richter and Bio-Thera Solutions have announced a European licensing deal worth potentially more than $100m for the Chinese biosimilar developer’s BAT2206 proposed rival to Stelara.

Roche Uses Its CGM To Target Unmet Needs In Diabetes Control

Roche Uses Its CGM To Target Unmet Needs In Diabetes Control

CE marking for its Accu-Chek Smartguide continuous glucose monitor means Roche is on the cusp of challenging existing major players in Europe with a device whose predictive algorithms can help sufferers plan and prepare longer into the future.

Alvotech’s Denosumab Biosimilar Takes Steps Forward With EMA Filing Acceptance

Alvotech’s Denosumab Biosimilar Takes Steps Forward With EMA Filing Acceptance

Alvotech is the latest to join several other competitors who have already submitted their denosumab biosimilar marketing authorization applications to the EMA.

Private Equity Poised To Take Control Of Opella But Sanofi Will Retain Sizable Stake

Private Equity Poised To Take Control Of Opella But Sanofi Will Retain Sizable Stake

Control of Sanofi Consumer Healthcare – recently rebranded as Opella – may soon pass to US private-equity firm CD&R but the French firm looks set to retain a substantial stake in a business which has some big Rx-to-OTC switches in the pipeline.

Replace Or Repair? Cardiologist, TriCares CEO On Changes In Tricuspid Valve Intervention

Replace Or Repair? Cardiologist, TriCares CEO On Changes In Tricuspid Valve Intervention

Tricuspid valve innovation has taken off since the US FDA’s 2023 authorizations of Edwards' Evoque and Abbott's TriClip systems. Whether to repair or replace tricuspid valves remains an open, nuanced question among cardiologists. Dr. Henrik Treede of University Hospital Mainz and TriCares CEO Ahmed Elmouelhi offer views on the evolving space.

Government And Industry Stakeholders Debate Future Of European Drug Supply

Government And Industry Stakeholders Debate Future Of European Drug Supply

Delegates from European institutions and industry representatives unpacked the many challenges of improved access to critical medicines on the continent in a session at this year’s European Health Forum.

ViiV Commits To Tripling Apretude PrEP Supply In Low Income States

ViiV Commits To Tripling Apretude PrEP Supply In Low Income States

Days after Gilead’s signing of voluntary licensing with six generic manufacturers for its HIV drug Sunleca, ViiV announced its commitment to ramping up Apretude’s supply to countries in need.

Get It Done In 100 Days: European Commission Told To Deliver On Revising Device Regulation

Get It Done In 100 Days: European Commission Told To Deliver On Revising Device Regulation

The European Parliament intends to send an official message to the European Commission to try and push for an early revision of the Medical Device Regulation.

EU Authority Mulls Paying For  Late-Stage Research As A Pull Incentive For Neglected Disease Drugs

EU Authority Mulls Paying For Late-Stage Research As A Pull Incentive For Neglected Disease Drugs

It is time for a much greater focus on pull incentives to ensure viable market conditions for medicines for neglected diseases that are traditionally regarded as unprofitable.

German OTC Marketing News: Launches From Bayer, Stada, Hermes And Klosterfrau

German OTC Marketing News: Launches From Bayer, Stada, Hermes And Klosterfrau

Bayer adds dry eye treatment to its Bepanthen skin care range; Stada launches special edition Elotrans supplement for Eintracht Frankfurt fans; Hermes offers chewable magnesium supplement; and Klosterfrau introduces Oyono Night extension to help troubled sleepers maintain their immunity.